文献速递胃肠外科围术期管理与 ERAS

儿童胚胎性肿瘤微创切除可维持肿瘤学完整性

Maintaining oncologic integrity with minimally invasive resection of pediatric embryonal tumors.
PubMed 文献 · Surgery · 2018-05-08

回顾性队列研究纳入202例儿童206个腔内胚胎性肿瘤,比较微创与开放切除。对体积小于100 mL的肿瘤,两种术式5年无复发生存和总生存无显著差异,微创手术出血少、手术时间短、住院时间短。

要点

  • 体积<100 mL的胚胎性肿瘤,微创与开放切除的5年生存无显著差异
  • 微创手术出血更少、手术时间更短、住院时间更短
  • 大肿瘤体积、小患者体型和影像学危险因素可能限制微创适用性

核心结论

  • 适当选择时,儿童胚胎性肿瘤微创切除尤其神经母细胞瘤可提供可接受的肿瘤学完整性。

研究设计与样本

  • 回顾性队列研究,查询Vanderbilt癌症登记库,纳入15年间202例儿童206个腔内胚胎性肿瘤。

主要发现

  • 178个肿瘤被切除,开放152例(85%),微创26例(15%)。
  • 体积<100 mL肿瘤中,微创与开放切除的5年无复发生存(P=.249)和总生存(P=.124)无显著差异。
  • 两种术式的切缘状态(P=.333)和淋巴结采样(P=.070)无差异。
  • 微创手术与出血减少(P<.001)、手术时间缩短(P=.002)和住院时间缩短(P<.001)相关。

关键数值与推荐

  • 微创手术多用于体积较小、分期较早且无影像学危险因素的神经母细胞瘤。

临床怎么用

  • 对于体积<100 mL且无影像学危险因素的儿童胚胎性肿瘤,可考虑微创切除以缩短治疗延迟。

局限性

  • 大肿瘤体积、小患者体型和影像学危险因素可能限制微创手术的更广泛应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Embryonal tumors arise typically in infants and young children and are often massive at presentation. Operative resection is a cornerstone in the multimodal treatment of embryonal tumors but potentially disrupts therapeutic timelines. When used appropriately, minimally invasive surgery can minimize treatment delays. The oncologic integrity and safety attainable with minimally invasive resection of embryonal tumors, however, remains controversial. METHODS: Query of the Vanderbilt Cancer Registry identified all children treated for intracavitary, embryonal tumors during a 15-year period. Tumors were assessed radiographically to measure volume (mL) and image-defined risk factors (neuroblastic tumors only) at time of diagnosis, and at preresection and postresection. Patient and tumor characteristics, perioperative details, and oncologic outcomes were compared between minimally invasive surgery and open resection of tumors of comparable size. RESULTS: A total of 202 patients were treated for 206 intracavitary embryonal tumors, of which 178 were resected either open (n = 152, 85%) or with minimally invasive surgery (n = 26, 15%). The 5-year, relapse-free, and overall survival were not significantly different after minimally invasive surgery or open resection of tumors having a volume less than 100 mL, corresponding to the largest resected with minimally invasive surgery (P = .249 and P = .124, respectively). No difference in margin status or lymph node sampling between the 2 operative approaches was detected (p = .333 and p = .070, respectively). Advantages associated with minimally invasive surgery were decreased blood loss (P < .001), decreased operating time (P = .002), and shorter hospital stay (P < .001). Characteristically, minimally invasive surgery was used for smaller volume and earlier stage neuroblastic tumors without image-defined risk factors. CONCLUSION: When selected appropriately, minimally invasive resection of pediatric embryonal tumors, particularly neuroblastic tumors, provides acceptable oncologic integrity. Large tumor volume, small patient size, and image-defined risk factors may limit the broader applicability of minimally invasive surgery.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Phelps HM, Ayers GD, Ndolo JM, et al. Maintaining oncologic integrity with minimally invasive resection of pediatric embryonal tumors. Surgery. 2018. PMID: 29751968. doi:10.1016/j.surg.2018.03.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。